Sarepta Therapeutics News and Activities

Presence

Sarepta Therapeutics develops genetic medicines for rare diseases. It provides gene therapy, RNA-based treatments, and related support services for patients, healthcare providers, and treatment centers.

Sarepta Therapeutics products and services overview:

Gene therapy
RNA therapies
Rare disease drugs
Diagnostic support
Patient services

Revenue: ~$2 billion

Employees: 1,800

Headquarters: Cambridge, United States (USA)

Sarepta Therapeutics is one of the...

Sarepta Therapeutics is a company listed under the stock ticker SRPT (US).

Executives

View the org chart displaying its 38 main executives

Most searched biographies at Sarepta Therapeutics

Popular executive movements at Sarepta Therapeutics

Douglas Ingram, who is President, Chief Executive Officer and Director will soon leave the company (posted on February 27 2026).
Bilal Arif, Chief Technical Operations Officer, has left the company (posted on October 6 2025).

Create your alert
to follow the executive moves at Sarepta Therapeutics.